reported that hnRNP-U is highly expressed in bladder cancer, and inhibited hnRNP-U may improve chemotherapy sensitivity by enhancing cisplatin-induced apoptosis of bladder cancer cells (52). Here, HNRNPU is linked to urinary bladder cancer.